Connect with us

NEWS

Russia to Begin Human Trials of AI-Powered Cancer Vaccine in 2025

Published

on

Russia is preparing to launch human trials of a groundbreaking cancer vaccine developed by the Gamaleya National Research Center for Epidemiology and Microbiology—the same institute behind the Sputnik COVID-19 vaccines.

Preclinical studies have reportedly shown that the vaccine can suppress tumor growth and prevent the spread of cancer (metastasis).

The vaccine is uniquely designed for each patient, using artificial intelligence to analyze the genetic makeup of their tumors.

RELATED NEWS  Atiku Celebrates Wife Titi on Her 75th Birthday With Touching Message

The first human trials, focusing on a melanoma-specific version of the vaccine, are expected to begin in late 2025 at the Hertsen Research Institute and the N.N. Blokhin National Medical Research Center in Moscow.

Share

Hi, I’m Babawale Busari — a passionate storyteller, content creator, and observer of the world around me. I share compelling stories, current events, digital trends, and insightful commentary that spark thought and conversation. Whether it’s news, culture, tech, or everyday experiences, I believe every detail matters. Thanks for stopping by — let's explore the world, one post at a time.

TRENDING

Discover more from Naijanewstoday

Subscribe now to keep reading and get access to the full archive.

Continue reading